OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Bamlanivimab for Prevention of COVID-19
Daniel R. Kuritzkes
JAMA (2021) Vol. 326, Iss. 1, pp. 31-31
Closed Access | Times Cited: 14
Daniel R. Kuritzkes
JAMA (2021) Vol. 326, Iss. 1, pp. 31-31
Closed Access | Times Cited: 14
Showing 14 citing articles:
Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19
Flonza Isa, Eduardo Forleo‐Neto, Jonathan Meyer, et al.
International Journal of Infectious Diseases (2022) Vol. 122, pp. 585-592
Open Access | Times Cited: 28
Flonza Isa, Eduardo Forleo‐Neto, Jonathan Meyer, et al.
International Journal of Infectious Diseases (2022) Vol. 122, pp. 585-592
Open Access | Times Cited: 28
Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives
Qiugang Zhu, Yan Xu, Ting Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27
Qiugang Zhu, Yan Xu, Ting Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27
Lessons we learned during the past four challenging years in the COVID-19 era: pharmacotherapy, long COVID complications, and vaccine development
Parisa Ghasemiyeh, Soliman Mohammadi‐Samani
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Parisa Ghasemiyeh, Soliman Mohammadi‐Samani
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 6
SARS-CoV-2: Recent Variants and Clinical Efficacy of Antibody-Based Therapy
Desh Deepak Singh, Anshul Sharma, Hae‐Jeung Lee, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 19
Desh Deepak Singh, Anshul Sharma, Hae‐Jeung Lee, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 19
Saving millions of lives but some resources squandered: emerging lessons from health research system pandemic achievements and challenges
Stephen Hanney, Sharon E. Straus, Bev Holmes
Health Research Policy and Systems (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 15
Stephen Hanney, Sharon E. Straus, Bev Holmes
Health Research Policy and Systems (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 15
Reappraising the Value of HIV-1 Vaccine Correlates of Protection Analyses
Per Johan Klasse, John P. Moore
Journal of Virology (2022) Vol. 96, Iss. 8
Open Access | Times Cited: 11
Per Johan Klasse, John P. Moore
Journal of Virology (2022) Vol. 96, Iss. 8
Open Access | Times Cited: 11
One-Step Quantification of anti-Covid-19 Antibodies via Dual Affinity Ratiometric Quenching Assays
Katie M. Kilgour, Brendan L. Turner, Michael A. Daniele, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 27, pp. 10368-10375
Open Access | Times Cited: 5
Katie M. Kilgour, Brendan L. Turner, Michael A. Daniele, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 27, pp. 10368-10375
Open Access | Times Cited: 5
Repeat Subcutaneous Administration of REGEN-COV® in Adults is Well-Tolerated and Prevents the Occurrence of COVID-19
Flonza Isa, Eduardo Forleo‐Neto, Jonathan Meyer, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 6
Flonza Isa, Eduardo Forleo‐Neto, Jonathan Meyer, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 6
Monoclonal Antibodies as Long-Acting Products: What Are We Learning From Human Immunodeficiency Virus (HIV) and Coronavirus Disease 2019 (COVID-19)?
Marina Caskey, Daniel R. Kuritzkes
Clinical Infectious Diseases (2022) Vol. 75, Iss. Supplement_4, pp. S530-S540
Open Access | Times Cited: 4
Marina Caskey, Daniel R. Kuritzkes
Clinical Infectious Diseases (2022) Vol. 75, Iss. Supplement_4, pp. S530-S540
Open Access | Times Cited: 4
CHITV: an updated combination treatment regimen for COVID-19
Yixin Yan, Yi Hao, Yun Ling, et al.
Elsevier eBooks (2024), pp. 2743-2751
Closed Access
Yixin Yan, Yi Hao, Yun Ling, et al.
Elsevier eBooks (2024), pp. 2743-2751
Closed Access
Management of COVID patients with convalescent plasma: Do we have the final word?
Francesco Menichetti, Marco Falcone, Giusy Tiseo
European Journal of Internal Medicine (2021) Vol. 95, pp. 13-16
Open Access | Times Cited: 4
Francesco Menichetti, Marco Falcone, Giusy Tiseo
European Journal of Internal Medicine (2021) Vol. 95, pp. 13-16
Open Access | Times Cited: 4
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019
Sebastian E. Sattui, Zachary S. Wallace
Rheumatic Disease Clinics of North America (2023) Vol. 49, Iss. 3, pp. 695-711
Open Access | Times Cited: 1
Sebastian E. Sattui, Zachary S. Wallace
Rheumatic Disease Clinics of North America (2023) Vol. 49, Iss. 3, pp. 695-711
Open Access | Times Cited: 1
Epigenetic features, methods, and implementations associated with COVID-19
Rwik Sen, Shreya Sarkar, Sarantis Chlamydas, et al.
Elsevier eBooks (2023), pp. 161-175
Closed Access
Rwik Sen, Shreya Sarkar, Sarantis Chlamydas, et al.
Elsevier eBooks (2023), pp. 161-175
Closed Access
Pharmacological and Non-pharmacological Intervention in Epidemic Prevention and Control: A Medical Perspective
Yanbing Xiong, Lijing Du, Jing Wang, et al.
Lecture notes on data engineering and communications technologies (2023), pp. 573-582
Closed Access
Yanbing Xiong, Lijing Du, Jing Wang, et al.
Lecture notes on data engineering and communications technologies (2023), pp. 573-582
Closed Access
